MediKredit distributes circulars to the healthcare industry to notify stakeholders of any important information or changes relating to NAPPI® codes.
| Reference | Subject | Effective Date | ||
|---|---|---|---|---|
| N009/2023 | Nappi Change in Number of Uses – Iso Clear |
01/09/2023 | Download | |
| N008/2023 | NAPPI Dosage form Change – Bayer Pty Ltd |
29/08/2023 | Download | |
| N007/2023 | NAPPI Change in Number of Uses – Respiratory Care Africa |
20/07/2023 | Download | |
| N006/2023 | NAPPI Change in Number of Uses – Mr First Aid |
20/07/2023 | Download | |
| N005/2023 | NAPPI change from Section 21 to SAHPRA Registered Product_Flucytosine mylan - Mylan (Pty) Ltd |
26/05/2023 | Download | |
| N004/2023 | NAPPI change from Section 21 Product to SAHPRA Registered Product |
06/04/2023 | Download | |
| N003/2023 | Involuntary Withdrawal of Products – Pholcodine Containing Medicines |
03/04/2023 | Download | |
| N002/2023 | Involuntary Withdrawal of Products- Pholcodine Containing Medicines |
30/03/2023 | Download | |
| N001/2023 | New NAPPI Code: Pfizer COVID-19 Paediatric Vaccine |
01/02/2023 | Download | |
| N018/2022 | MediKredit Head Office Physical Address Change |
01/01/2023 | Download | |
| N017/2022 | NAPPI Change from Section 21 to Registered Product – Takeda Pty Ltd |
07/12/2022 | Download | |
| N016/2022 | NAPPI Change in number of uses - Surgical Innovations |
08/11/2022 | Download | |
| N015/2022 | NAPPI Change in Number of Uses – Iso Clear |
08/11/2022 | Download | |
| N014/2022 | NAPPI Change in Number of Uses- Johnson & Johnson Medical (Pty) Ltd-CSS |
25/10/2022 | Download | |
| N013/2022 | NAPPI Change from Section 21 to SAHPRA Registered Product - Alecensa |
11/08/2022 | Download | |
| N012/2022 | NAPPI Change From Section 21 to SAHPRA Registered Product – Uptravi Range |
20/07/2022 | Download | |
| N011/2022 | Notification of NAPPI Code Changes – Barr Cocaine and Morphine Powders |
15/07/2022 | Download | |
| N010/2022 | Notification of NAPPI Change From SecNotification of NAPPI Change From Section 21 to SAHPRA Registered Product – Uptravi 1200 mcg TABtion 21 to SAHPRA Registered Product – Uptravi 1200 mcg TAB |
01/07/2022 | Download | |
| N009/2022 | Notification of NAPPI Change from Section 21 Products to SAHPRA Registered - Imfinzi |
27/06/2022 | Download | |
| N008/2022 | NAPPI Change in Number of Uses – Selective Surgicals CC |
22/06/2022 | Download | |
| N007/2022 | NAPPI Change From Section 21 Product to SAHPRA Registered Product-Pfizer COVID-19 Vaccine.pdf |
14/06/2022 | Download | |
| N006/2022 | Notification of NAPPI Change from Section 21 Product to SAHPRA Registered Product – MSD Pty Ltd |
26/04/2022 | Download | |
| N005/2022 | Notification of NAPPI Change from Section 21 Product to SAHPRA Registered - Blinicyto |
07/04/2022 | Download | |
| N004/2022 | NAPPI Change in number of uses Vertice Healthcare |
31/03/2022 | Download | |
| N003/2022 | Notification of Change in Number of Uses SSM Mthembu |
18/03/2022 | Download | |
| N037/2021 | Notification of Change in number of uses - Perryhill |
09/12/2021 | Download | |
| N036/2021 | Notification of Change in number of uses - Johnson & Johnson |
03/12/2021 | Download | |
| N035/2021 | Notification of Change in number of uses - Perryhill International |
04/11/2021 | Download | |
| N034/2021 | Notification of Section 21 Products Changed to SAHPRA Registered Products - Lynparza Astra Zeneca Pharmaceuticals |
04/11/2021 | Download | |
| N033/2021 | Notification of Change in number of uses - Creatori Health |
22/10/2021 | Download |